Vivaldi Capital Management’s Halozyme HALO Stock Holding History

Vivaldi Capital Management’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-24,499	Closed	-$1.58M	–	92
2026 Q1	$1.58M	Sell	24,499 -3,190	-12%	-$225K	0.22%	82
2025 Q4	$1.86M	Sell	27,689 -5,452	-16%	-$367K	0.25%	78
2025 Q3	$2.43M	Sell	33,141 -1,837	-5%	-$122K	0.34%	70
2025 Q2	$1.82M	Hold	34,978	–	–	0.27%	80
2025 Q1	$2.23M	Hold	34,978	–	–	0.36%	66
2024 Q4	$1.95M	Hold	34,978	–	–	0.3%	68
2024 Q3	$2M	Sell	34,978 -100	-0.3%	-$5.73K	0.58%	41
2024 Q2	$1.84M	Hold	35,078	–	–	0.52%	42
2024 Q1	$1.51M	Hold	35,078	–	–	0.44%	59
2023 Q4	$1.22M	Hold	35,078	–	–	0.36%	75
2023 Q3	$1.34M	Hold	35,078	–	–	0.44%	60
2023 Q2	$1.27M	Buy	35,078 +600	+2%	+$20.5K	0.39%	63
2023 Q1	$1.32M	Hold	34,478	–	–	0.4%	60
2022 Q4	$1.9M	Buy	+34,478	New	+$1.77M	0.47%	66

Other funds holding HALO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Vivaldi Capital Management's HALO Position: Q2 2026 in Review

Vivaldi Capital Management sold out of Halozyme (HALO) in Q2 2026, closing a stake of 24,499 shares — an estimated $1.58M sold.

Vivaldi Capital Management first reported a position in HALO in Q4 2022 and held it in 14 quarters. The position peaked at $2.43M in Q3 2025. 668 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

Vivaldi Capital Management reported no remaining Halozyme position as of Q2 2026 after selling out during the quarter.
Vivaldi Capital Management sold 24,499 Halozyme shares in Q2 2026, an estimated $1.58M.
Vivaldi Capital Management first reported a position in Halozyme in Q4 2022 and held it in 14 quarters.
Vivaldi Capital Management's Halozyme position peaked at $2.43M in Q3 2025.
668 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Vivaldi Capital Management's 13F filing for Q2 2026.